Literature DB >> 3011165

Stereospecific antiarrhythmic effect of opioid receptor antagonists in myocardial ischaemia.

J R Parratt, R Sitsapesan.   

Abstract

The effects of the stereoisomers of two different antagonists at opioid receptors were examined on the ventricular arrhythmias that result from acute coronary artery ligation in anaesthetized male rats. (-)-Mr 1452(but not the (+)-isomer, Mr 1453) reduced, in a dose-dependent manner, the number of ventricular ectopic beats and the incidence or duration of both ventricular tachycardia and fibrillation. (-)-WIN 44,441-3 (but not its (+)-isomer, WIN 44,441-2) had a similar protective effect in ischaemia. These results suggest that antagonism of the effects of endogenous opioid peptides at specific receptors results in reduced severity of arrhythmias in myocardial ischaemia.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3011165      PMCID: PMC1916799          DOI: 10.1111/j.1476-5381.1986.tb14577.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  5 in total

1.  Multiple opioid receptor profile in vitro and activity in vivo of the potent opioid antagonist Win 44,441-3.

Authors:  S J Ward; A K Pierson; W F Michne
Journal:  Life Sci       Date:  1983       Impact factor: 5.037

2.  Presynaptic inhibitory opioid delta- and kappa-receptors in a branch of the rabbit ileocolic artery.

Authors:  I Von Kügelgen; P Illes; D Wolf; K Starke
Journal:  Eur J Pharmacol       Date:  1985-11-26       Impact factor: 4.432

3.  Naloxone inhibits early arrhythmias resulting from acute coronary ligation.

Authors:  O Fagbemi; I Leprán; J R Parratt; L Szekeres
Journal:  Br J Pharmacol       Date:  1982-08       Impact factor: 8.739

4.  Coronary artery ligation in anesthetized rats as a method for the production of experimental dysrhythmias and for the determination of infarct size.

Authors:  C Clark; M I Foreman; K A Kane; F M McDonald; J R Parratt
Journal:  J Pharmacol Methods       Date:  1980-06

5.  Antiarrhythmic actions of meptazinol, a partial agonist at opiate receptors, in acute myocardial ischaemia.

Authors:  O Fagbemi; K A Kane; I Leprán; J R Parratt; L Szekeres
Journal:  Br J Pharmacol       Date:  1983-03       Impact factor: 8.739

  5 in total
  7 in total

1.  The effects of drugs interacting with opioid receptors on the early ventricular arrhythmias arising from myocardial ischaemia.

Authors:  R Sitsapesan; J R Parratt
Journal:  Br J Pharmacol       Date:  1989-07       Impact factor: 8.739

2.  Failure to reproduce the in vitro cardiac electrophysiological effects of naloxone in humans.

Authors:  K G Oldroyd; A C Rankin; C E Gray; K Harvey; W Borland; A P Rae; S M Cobbe
Journal:  Br J Clin Pharmacol       Date:  1994-03       Impact factor: 4.335

3.  The antiarrhythmic and cardiac electrophysiological effects of buprenorphine.

Authors:  G Boachie-Ansah; R Sitsapesan; K A Kane; J R Parratt
Journal:  Br J Pharmacol       Date:  1989-07       Impact factor: 8.739

4.  Cardiovascular actions of the kappa-agonist, U-50,488H, in the absence and presence of opioid receptor blockade.

Authors:  M K Pugsley; W P Penz; M J Walker; T M Wong
Journal:  Br J Pharmacol       Date:  1992-03       Impact factor: 8.739

5.  Stereospecific antiarrhythmic effects of naloxone against myocardial ischaemia and reperfusion in the dog.

Authors:  A Y Lee
Journal:  Br J Pharmacol       Date:  1992-12       Impact factor: 8.739

6.  Anti-arrhythmic activities of opioid agonists and antagonists and their stereoisomers.

Authors:  Y Sarne; A Flitstein; E Oppenheimer
Journal:  Br J Pharmacol       Date:  1991-03       Impact factor: 8.739

Review 7.  Prospects for Creation of Cardioprotective and Antiarrhythmic Drugs Based on Opioid Receptor Agonists.

Authors:  Leonid N Maslov; Igor Khaliulin; Peter R Oeltgen; Natalia V Naryzhnaya; Jian-Ming Pei; Stephen A Brown; Yury B Lishmanov; James M Downey
Journal:  Med Res Rev       Date:  2016-05-16       Impact factor: 12.944

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.